Individualised Estimation of Quality-adjusted Survival Benefit and Cost-effectiveness of Proton Beam Therapy in Intermediate-stage Hodgkin Lymphoma.
Journal article
Jones DA. et al, (2023), Clin Oncol (R Coll Radiol)
Predicted cardiac and second cancer risks for patients undergoing VMAT for mediastinal Hodgkin lymphoma.
Journal article
Houlihan OA. et al, (2022), Clin Transl Oncol
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).
Journal article
Lyon AR. et al, (2022), Eur Heart J Cardiovasc Imaging
Guideline for the first-line management of Classical Hodgkin Lymphoma - A British Society for Haematology guideline.
Journal article
Follows GA. et al, (2022), Br J Haematol, 197, 558 - 572
Colorectal cancer risk following radiotherapy and procarbazine for Hodgkin lymphoma
Conference paper
Shakir R. et al, (2022), RADIOTHERAPY AND ONCOLOGY, 170, S257 - S257
Estimating risk of radiation toxicity for lymphoma patients using pre-chemotherapy PET-CT scans
Conference paper
Shakir R. et al, (2022), RADIOTHERAPY AND ONCOLOGY, 170, S253 - S255
Proton Therapy in Supradiaphragmatic Lymphoma: Predicting Treatment-Related Mortality to Help Optimize Patient Selection.
Journal article
Ntentas G. et al, (2022), Int J Radiat Oncol Biol Phys, 112, 913 - 925
Informing radiotherapy decisions in stage I/IIa Hodgkin lymphoma: modeling life expectancy using radiation dosimetry.
Journal article
Jones DA. et al, (2022), Blood Adv, 6, 909 - 919
Pericardial Effusion during Proton Therapy in a Patient with Chemorefractory Hodgkin Lymphoma.
Journal article
Way A. et al, (2022), Int J Part Ther, 8, 76 - 81
Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography-Directed Therapy for Early-Stage Hodgkin Lymphoma.
Journal article
Cutter DJ. et al, (2021), J Clin Oncol, 39, 3591 - 3601
Predicted cardiac and second cancer risks following treatment for Hodgkin lymphoma in Ireland
Conference paper
Houlihan O. et al, (2021), RADIOTHERAPY AND ONCOLOGY, 161, S900 - S901
Limited-stage diffuse large B-cell lymphoma: current management and challenges.
Journal article
Zhang X-Y. et al, (2021), Br J Haematol
An Excess Mortality Risk Analysis of Proton Beam versus Optimal Photon Radiotherapy for Mediastinal Hodgkin Lymphoma: Who May Benefit Most?
Conference paper
Ntentas G. et al, (2020), INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 108, S140 - S141
Dose-response relationships for radiation-related heart disease: Impact of uncertainties in cardiac dose reconstruction.
Journal article
Ntentas G. et al, (2020), Radiother Oncol
Risk of cerebrovascular disease among 13,457 five-year survivors of childhood cancer: a population based cohort study.
Journal article
Reulen RC. et al, (2020), Int J Cancer
Pleural plasmacytomas - the role of radiotherapy.
Journal article
Yeoh K-W. et al, (2020), Br J Haematol
Twenty five year risks of breast cancer mortality in 500,000 women
Conference paper
Taylor C. et al, (2020), BREAST CANCER RESEARCH AND TREATMENT, 180, 589 - 589
Patterns and Predictors of Relapse Following Radical Chemoradiation Therapy Delivered Using Intensity Modulated Radiation Therapy With a Simultaneous Integrated Boost in Anal Squamous Cell Carcinoma.
Conference paper
Shakir R. et al, (2020), Int J Radiat Oncol Biol Phys, 106, 329 - 339
Cardiovascular and Pulmonary Late Effects.
Chapter
Aleman BMP. and Cutter D., (2020), Hodgkin Lymphoma